GlassScriptPhysician profile
Aneesh Bapat
NPI 1790051712
$39,617.96
in general payments reported to CMS, 2019-2025
9 companies · $3,918 in 2025
The $3,918 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,244 · 2020: $7,500 · 2021: $15K · 2022: $6,476 · 2023: $1,967 · 2024: $1,838 · 2025: $3,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,284 · Food and Beverage: $2,381 · Honoraria: $58.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,284.04 |
| Food and Beverage | $2,380.90 |
| Honoraria | $58.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiologs Technologies | $14,437.50 | 2021 | |
| Biotronik INC. | $7,593.03 | 2021-2025 | Acticor 7 Vr-T Dx |
| Medtronic, INC. | $6,146.36 | 2022-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Selectsecure |
| Boston Scientific Corporation | $5,818.70 | 2019-2025 | General - Therapies |
| Medtronic Vascular, INC. | $5,000.00 | 2020 | |
| Becton, Dickinson and Company | $300.00 | 2022 | |
| Impulse Dynamics (USA) INC. | $165.14 | 2022-2025 | Optimizer |
| Abbott Laboratories | $99.23 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $58.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aneesh Bapat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.